$9.11
At close: Apr 16, 7:38 PM EDT
$9.39
0.283.07%
Pre-Market: Apr 16, 7:38 PM EDT
Comments
Loading...
Amarin Corp (AMRN) Forecast
NewsEarningsAmarin Corp (AMRN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Amarin Corp Stock Price, Quotes and Forecasts | NASDAQ:AMRN | Benzinga
Explore Amarin Corp stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for AMRN.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Amarin Corp (AMRN) stock?
You can purchase shares of Amarin Corp (NASDAQ:AMRN) through any online brokerage.
Who are Amarin Corp (AMRN) competitors?
Other companies in Amarin Corp’s space includes: Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA), Sarepta Therapeutics (NASDAQ:SRPT), Ionis Pharmaceuticals (NASDAQ:IONS) and Alkermes (NASDAQ:ALKS).
What is the forecast, or price target, for Amarin Corp (AMRN) stock?
Amarin Corp has a consensus price target of $2.85.
What is the current price for Amarin Corp (AMRN)?
The stock price for Amarin Corp (NASDAQ: AMRN) is $9.39 last updated April 16, 2025 at 7:38 PM EDT.
Does Amarin Corp (AMRN) pay a dividend?
There are no upcoming dividends for Amarin Corp.
When is Amarin Corp (NASDAQ:AMRN) reporting earnings?
Amarin Corp’s Q1 earnings are confirmed for Monday, May 5, 2025.
Is Amarin Corp (AMRN) going to split?
There is no upcoming split for Amarin Corp.
What sector and industry does Amarin Corp (AMRN) operate in?
Amarin Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
